CMS Entry id: 2709 | Channel: Blog landing page | Template: blog/index

Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

Blog

Remote symptom monitoring using wearable technology

Capturing daily fluctuations in mood and cognition can help to more accurately monitor treatment response - but is this feasible for patients with depression?

In research presented at CNS2020, we examined the feasibility of high-frequency cognitive assessments, and their relationship with daily measures of depressive symptoms and physical activity.

COVID-19 and Virtual Trials: What does the FDA’s guidance mean for drug development?

The FDA have released guidance urging clinical trials to go virtual where possible in response to the COVID-19 pandemic – so what are the best methods for ensuring patient safety and trial integrity during this transition? In this article, we will discuss some of the important aspects to consider when taking a therapeutic trial from the clinic to the patient’s home.

The full FDA Guidance on Conduct of Clinical Trials of Medical Products During the COVID-19 Pandemic is available here

web-based testing, wearables, voice recognition, voice, virtual clinical trials, technology, swm, subjective measures, stigma, social cognition, smartphones, schizophrenia research, schizophrenia, safety, research funding, research, remote testing, regulations, rare disease, psychosis, prodromal, pro-cognitive, press release, presenteeism, precision psychiatry, pre-clinical, poster, personalised medicine, patient-centric, patient recruitment, parkinson's disease, pal, paired associates learning, occupational health, objective measures, normative data, neuroscience, near-patient testing, multiple sclerosis, ms, modelling, mental wellbeing, mental health at work, mental health, mdd, mci, major depression, machine learning, longitudinal, hot cognition, high-frequency testing, healthcare, grant, funding, fatigue, ert, epidemiology, emotion recognition, ecoa, ebt, early career researchers, early alzheimer's disease, drug development, digital tools, digital health, depression, dementia, covid-19, cognitive wellbeing, cognitive testing, cognitive science, cognitive safety, cognitive research, cognitive impairment, cognitive function, cognitive dysfunction, cognitive deficits, cognitive biomarkers, cognitive assessment, cognition kit, cognition, cns summit, clinical trials, clinical trial, cias, chronic illness, chronic health conditions, cgt, cantab testimonial, cantab research grant, cantab, brain health, biomarkers, automatic speech recognition, autism, attention, asr, alzheimer's disease, absenteeism, aaic2020,